Effects on bone mineral density of 12-month goserelin treatment in over 40-year-old women with uterine myomas

[1]  R. Gleason,et al.  A Prospective, Randomized Trial of Gonadotropin‐Releasing Hormone Agonist Plus Estrogen‐Progestin or Progestin “Add‐Back” Regimens for Women With Leiomyomata Uteri , 1993, The Journal of clinical endocrinology and metabolism.

[2]  M. Dawood,et al.  Impact of medical treatment of endometriosis on bone mass. , 1993, American journal of obstetrics and gynecology.

[3]  C. Christiansen,et al.  2 Current techniques for bone mass measurement , 1991 .

[4]  L. Fedele,et al.  Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[5]  K. Elkind-Hirsch,et al.  Sequential Gn‐RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata , 1990, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  P. Vercellini,et al.  Use of Goserelin Depot, A Gonadotropin‐Releasing Hormone Agonist, for the Treatment of Menorrhagia and Severe Anemia in Women with Leiomyomata Uteri , 1990, Acta obstetricia et gynecologica Scandinavica.

[7]  T. Shawker,et al.  Efficacy of a gonadotropin‐releasing hormone agonist in the treatment of uterine leiomyomata; Long‐term follow‐up , 1990, Fertility and sterility.

[8]  R. Shaw,et al.  Long‐term follow‐up of patients with uterine fibroids after treatment with the LHRH agonist buserelin , 1989, British journal of obstetrics and gynaecology.

[9]  T. Shawker,et al.  Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. , 1989 .

[10]  B. Lees,et al.  Determinants of bone density in normal women: risk factors for future osteoporosis? , 1989, BMJ.

[11]  R. Barbieri,et al.  A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. , 1988, Fertility and sterility.

[12]  C. Christiansen,et al.  Current techniques for bone mass measurement. , 1991, Bailliere's clinical obstetrics and gynaecology.